271. Ankylosing spondylitis Clinical trials / Disease details

Clinical trials : 574 / Drugs : 359 - (DrugBank : 68) / Drug target genes : 41 - Drug target pathways : 146

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02469753 (ClinicalTrials.gov)	October 23, 2015	9/6/2015	Interest of Continuous Non-Steroidal Anti-Inflammatory Drug Treatment in Ankylosing Spondylitis Patients Treated by Anti-TNF Therapy in the Prevention of Radiographic Outcomes	Interest of Continuous Non-Steroidal Anti-Inflammatory Drug Treatment in Ankylosing Spondylitis Patients Treated by Anti-TNF Therapy in the Prevention of Radiographic Outcomes	Ankylosing Spondylitis	Drug: NSAIDs;Drug: anti-TNF	University Hospital, Bordeaux	NULL	Active, not recruiting	18 Years	N/A	All	188	Phase 3	France;Monaco
2	NCT01038011 (ClinicalTrials.gov)	June 2004	15/12/2009	Efficacy and Safety of Risedronate (Actonel), a Third Generation Bisphosphonate in Patients With Ankylosing Spondylitis: a Phase 2 Pilot Study		Ankylosing Spondylitis	Drug: drug treatment	University of Zurich	Sanofi	Completed	18 Years	N/A	All		Phase 2	Switzerland